AkzoNobel media conference call invitation
Jun 01, 2017 11:42 am UTC| Business
Dear editor, We would like to invite you to the 15.00h CET media conference call, for today, June 1, 2017, hosted by our CEO Ton Büchner. Please find dial in details below. Conference call dial-in number ...
How to Create Better Business Plans
Jun 01, 2017 11:41 am UTC| Business
Do you struggle to create and implement effective plans that benefit your business? If so, you need to reconsider how you carry out this important business activity. Once you learn to plan in the proper way, you should...
Jun 01, 2017 11:41 am UTC| Business
CARMIEL, Israel, June 01, 2017 -- Protalix BioTherapeutics, Inc. (NYSE MKT:PLX) (TASE:PLX), announced today that a Supplemental New Drug Application (sNDA) submitted to the U.S. Food and Drug Administration (FDA) has...
Jun 01, 2017 11:41 am UTC| Business
CARMIEL, Israel, June 01, 2017 -- Protalix BioTherapeutics, Inc. (NYSE MKT:PLX) (TASE:PLX), announced today that a Supplemental New Drug Application (sNDA) submitted to the U.S. Food and Drug Administration (FDA) has...
Jun 01, 2017 11:41 am UTC| Business
CARMIEL, Israel, June 01, 2017 -- Protalix BioTherapeutics, Inc. (NYSE MKT:PLX) (TASE:PLX), announced today that a Supplemental New Drug Application (sNDA) submitted to the U.S. Food and Drug Administration (FDA) has...
Jun 01, 2017 11:41 am UTC| Business
CARMIEL, Israel, June 01, 2017 -- Protalix BioTherapeutics, Inc. (NYSE MKT:PLX) (TASE:PLX), announced today that a Supplemental New Drug Application (sNDA) submitted to the U.S. Food and Drug Administration (FDA) has...
Jun 01, 2017 11:41 am UTC| Business
CARMIEL, Israel, June 01, 2017 -- Protalix BioTherapeutics, Inc. (NYSE MKT:PLX) (TASE:PLX), announced today that a Supplemental New Drug Application (sNDA) submitted to the U.S. Food and Drug Administration (FDA) has...
Australia’s Corporate Regulator Urges Pension Funds to Boost Technology Investment as Industry Grows